vs
Concentra Group Holdings Parent, Inc.（CON）与因美纳（ILMN）财务数据对比。点击上方公司名可切换其他公司
因美纳的季度营收约是Concentra Group Holdings Parent, Inc.的1.9倍（$1.1B vs $569.6M），因美纳净利率更高（12.3% vs 9.2%，领先3.1%），Concentra Group Holdings Parent, Inc.同比增速更快（13.7% vs 4.8%），因美纳自由现金流更多（$251.0M vs $9.9M）
Concentra是美国的职业医疗服务商，1979年成立于得克萨斯州阿马里洛，总部位于得克萨斯州艾迪生。业务覆盖美国47个州，运营627家职业医疗中心和410个雇主驻地现场诊所，美国每7起职业伤害案例中就有1起由该机构提供诊疗服务。
因美纳是总部位于美国加利福尼亚州圣迭戈的生物技术企业，成立于1998年4月，专注研发、生产及销售用于分析基因变异与生物功能的集成系统，产品及服务覆盖测序、基因分型、基因表达、蛋白质组学等领域，业务遍及全球超155个国家和地区。
CON vs ILMN — 直观对比
营收规模更大
ILMN
是对方的1.9倍
$569.6M
营收增速更快
CON
高出8.9%
4.8%
净利率更高
ILMN
高出3.1%
9.2%
自由现金流更多
ILMN
多$241.1M
$9.9M
损益表 — Q1 FY2026 vs Q1 FY2027
| 指标 | | |
|---|---|---|
| 营收 | $569.6M | $1.1B |
| 净利润 | $52.3M | $134.0M |
| 毛利率 | — | 66.1% |
| 营业利润率 | 16.8% | 19.2% |
| 净利率 | 9.2% | 12.3% |
| 营收同比 | 13.7% | 4.8% |
| 净利润同比 | 28.7% | — |
| 每股收益（稀释后） | $0.39 | $0.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CONILMN
| Q1 26 | $569.6M | $1.1B | ||
| Q4 25 | $539.1M | $1.2B | ||
| Q3 25 | $572.8M | — | ||
| Q2 25 | $550.8M | — | ||
| Q1 25 | $500.8M | — | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | $489.6M | $1.1B | ||
| Q2 24 | $477.9M | $1.1B |
净利润CONILMN
| Q1 26 | $52.3M | $134.0M | ||
| Q4 25 | $34.7M | $334.0M | ||
| Q3 25 | $48.3M | — | ||
| Q2 25 | $44.6M | — | ||
| Q1 25 | $38.9M | — | ||
| Q4 24 | — | $186.0M | ||
| Q3 24 | $44.3M | $705.0M | ||
| Q2 24 | $51.7M | $-2.0B |
毛利率CONILMN
| Q1 26 | — | 66.1% | ||
| Q4 25 | — | 65.5% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 65.9% | ||
| Q3 24 | — | 69.0% | ||
| Q2 24 | — | 64.8% |
营业利润率CONILMN
| Q1 26 | 16.8% | 19.2% | ||
| Q4 25 | 12.9% | 17.4% | ||
| Q3 25 | 16.5% | — | ||
| Q2 25 | 16.3% | — | ||
| Q1 25 | 16.0% | — | ||
| Q4 24 | — | 15.8% | ||
| Q3 24 | 17.6% | 68.6% | ||
| Q2 24 | 17.6% | -147.2% |
净利率CONILMN
| Q1 26 | 9.2% | 12.3% | ||
| Q4 25 | 6.4% | 28.8% | ||
| Q3 25 | 8.4% | — | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | 7.8% | — | ||
| Q4 24 | — | 16.8% | ||
| Q3 24 | 9.1% | 65.3% | ||
| Q2 24 | 10.8% | -178.8% |
每股收益（稀释后）CONILMN
| Q1 26 | $0.39 | $0.87 | ||
| Q4 25 | $0.27 | $2.16 | ||
| Q3 25 | $0.38 | — | ||
| Q2 25 | $0.35 | — | ||
| Q1 25 | $0.30 | — | ||
| Q4 24 | — | $1.16 | ||
| Q3 24 | $0.37 | $4.42 | ||
| Q2 24 | $0.50 | $-12.48 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.2B |
| 总债务越低越好 | $1.6B | — |
| 股东权益账面价值 | $424.7M | $2.7B |
| 总资产 | $2.9B | $6.6B |
| 负债/权益比越低杠杆越低 | 3.68× | — |
8季度趋势，按日历期对齐
现金及短期投资CONILMN
| Q1 26 | — | $1.2B | ||
| Q4 25 | $79.9M | $1.6B | ||
| Q3 25 | $49.9M | — | ||
| Q2 25 | $73.9M | — | ||
| Q1 25 | $52.1M | — | ||
| Q4 24 | — | $93.0M | ||
| Q3 24 | $136.8M | $70.0M | ||
| Q2 24 | $50.7M | $74.0M |
总债务CONILMN
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $3.0M | — |
股东权益CONILMN
| Q1 26 | $424.7M | $2.7B | ||
| Q4 25 | $393.3M | $2.7B | ||
| Q3 25 | $385.5M | — | ||
| Q2 25 | $342.6M | — | ||
| Q1 25 | $307.1M | — | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | $277.8M | $2.1B | ||
| Q2 24 | $1.2B | $1.4B |
总资产CONILMN
| Q1 26 | $2.9B | $6.6B | ||
| Q4 25 | $2.9B | $6.6B | ||
| Q3 25 | $2.8B | — | ||
| Q2 25 | $2.8B | — | ||
| Q1 25 | $2.7B | — | ||
| Q4 24 | — | $6.3B | ||
| Q3 24 | $2.5B | $6.0B | ||
| Q2 24 | $2.4B | $6.1B |
负债/权益比CONILMN
| Q1 26 | 3.68× | — | ||
| Q4 25 | 3.98× | — | ||
| Q3 25 | 4.15× | — | ||
| Q2 25 | 4.82× | — | ||
| Q1 25 | 5.27× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.30× | — | ||
| Q2 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.0M | $289.0M |
| 自由现金流经营现金流 - 资本支出 | $9.9M | $251.0M |
| 自由现金流率自由现金流/营收 | 1.7% | 23.0% |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 0.40× | 2.16× |
| 过去12个月自由现金流最近4个季度 | $211.0M | $1.1B |
8季度趋势，按日历期对齐
经营现金流CONILMN
| Q1 26 | $21.0M | $289.0M | ||
| Q4 25 | $118.7M | $321.0M | ||
| Q3 25 | $60.6M | — | ||
| Q2 25 | $88.4M | — | ||
| Q1 25 | $11.7M | — | ||
| Q4 24 | — | $364.0M | ||
| Q3 24 | $65.9M | $316.0M | ||
| Q2 24 | — | $80.0M |
自由现金流CONILMN
| Q1 26 | $9.9M | $251.0M | ||
| Q4 25 | $98.5M | $267.0M | ||
| Q3 25 | $39.4M | — | ||
| Q2 25 | $63.2M | — | ||
| Q1 25 | $-4.0M | — | ||
| Q4 24 | — | $335.0M | ||
| Q3 24 | $50.8M | $284.0M | ||
| Q2 24 | — | $49.0M |
自由现金流率CONILMN
| Q1 26 | 1.7% | 23.0% | ||
| Q4 25 | 18.3% | 23.0% | ||
| Q3 25 | 6.9% | — | ||
| Q2 25 | 11.5% | — | ||
| Q1 25 | -0.8% | — | ||
| Q4 24 | — | 30.3% | ||
| Q3 24 | 10.4% | 26.3% | ||
| Q2 24 | — | 4.4% |
资本支出强度CONILMN
| Q1 26 | — | — | ||
| Q4 25 | 3.7% | — | ||
| Q3 25 | 3.7% | — | ||
| Q2 25 | 4.6% | — | ||
| Q1 25 | 3.1% | — | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | 3.1% | 3.0% | ||
| Q2 24 | — | 2.8% |
现金转化率CONILMN
| Q1 26 | 0.40× | 2.16× | ||
| Q4 25 | 3.42× | 0.96× | ||
| Q3 25 | 1.26× | — | ||
| Q2 25 | 1.98× | — | ||
| Q1 25 | 0.30× | — | ||
| Q4 24 | — | 1.96× | ||
| Q3 24 | 1.49× | 0.45× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CON
| Workers' compensation | $337.7M | 59% |
| Employer services | $172.4M | 30% |
| Onsite health clinics | $37.2M | 7% |
| Other | $14.5M | 3% |
| Consumer health | $7.8M | 1% |
ILMN
| Product revenue | $917.0M | 84% |
| Service and other revenue | $174.0M | 16% |
